This study thus reveals a new target for the development of novel drugs targeting pDC activity to treat hematopoietic disorders during chronic HIV-1 infection and also demonstrates the utility of humanized mice to investigate important questions on HIV-1-mediated hematological abnormalities in the BM in vivo. This evidence concerns the gene PDC and HIV-1 infection.